Immediate Impact
1 by Nobel laureates 5 from Science/Nature 54 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Works of Clifford DiLea being referenced
Phase 1 dose-escalation study of STRO-002, an antifolate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced, progressive platinum-resistant/refractory epithelial ovarian cancer (EOC).
2021
Targeting the CXCR4 Pathway: Safety, Tolerability and Clinical Activity of Ulocuplumab (BMS-936564), an Anti-CXCR4 Antibody, in Relapsed/Refractory Acute Myeloid Leukemia
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Clifford DiLea | 138 | 41 | 66 | 118 | 70 | 23 | 431 | |
| David J. Sweeny | 128 | 23 | 50 | 152 | 88 | 30 | 442 | |
| Wayne D. Brenckman | 148 | 30 | 36 | 143 | 49 | 15 | 438 | |
| Loeckie De Zwart | 87 | 21 | 50 | 87 | 82 | 23 | 439 | |
| Anjaneya Chimalakonda | 103 | 37 | 18 | 112 | 84 | 28 | 434 | |
| Nandi J. Reddy | 186 | 17 | 82 | 190 | 66 | 22 | 493 | |
| Ellen Scheers | 73 | 18 | 36 | 135 | 72 | 13 | 396 | |
| Vladimir Piotrovsky | 165 | 19 | 41 | 196 | 45 | 12 | 462 | |
| Kevin Dykstra | 90 | 33 | 35 | 93 | 29 | 23 | 511 | |
| Kosalaram Goteti | 87 | 28 | 19 | 130 | 59 | 32 | 467 | |
| S. Bussa | 167 | 6 | 113 | 130 | 56 | 17 | 457 |
All Works
Loading papers...